Weight loss medication entering into the mainstream could fundamentally reshape how millions of people shop and what retailers choose to sell, according to new research.
GLP-1s are already influencing spending habits across the UK but the approval of the first oral pill this month will drive a more powerful shift, PwC Strategy& found in a study.
